Automated partial occlusion for truncal hemorrhage control sbir phase II award
Ended Definitive Contract Awarded Last action
- Contract number
- HR001122C0128
- Awardee
-
Zymeron Corporation UEI GAMMMRQ6QMN1
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $989,815
Award facts
- Opportunity
-
- Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Pre-Solicitation · HR001120S0019 · Posted Feb 12, 2020
- Contract value 67% obligated
-
- $989,815.00 Current, with exercised options
- $1,484,722.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rural Hall, NC 27099, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $488,062 | |
| Original award | $501,753 |
About this award
The Defense Advanced Research Projects Agency awarded a $1.484 million definitive contract to Zymeron Corporation for automated partial occlusion technology for truncal hemorrhage control on August 26, 2022, under a total small business set-aside.
Zymeron Corporation is a minority-owned small business. The contract is priced on a cost-plus-fixed-fee basis with a ceiling value of $1.484 million. Place of performance is Rural Hall, NC. The ultimate completion date is August 25, 2026.
This is a Phase II Small Business Innovation Research award. The originating pre-solicitation, posted February 12, 2020, announced rolling SBIR and STTR funding opportunities across multiple technical domains including biomedical research. Phase II efforts support prototype development and proof-of-concept work within periods of performance up to 36 months.
Quick answers
Who was awarded contract HR001122C0128?
HR001122C0128 was awarded to Zymeron Corporation by Defense Advanced Research Projects Agency (Department of Defense) on August 26, 2022.
How much is contract HR001122C0128 worth?
The government has obligated $989,815 on HR001122C0128. Its potential value, with all options, is $1,484,722.
Was contract HR001122C0128 competed?
The extent of competition for HR001122C0128 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award